CCEL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.
Cryo-Cell International Inc's cash flow for capital expenditures for the three months ended in Nov. 2014 was $-0.03 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Nov. 2014 was $-0.12 Mil.
Cryo-Cell International Inc Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Nov. 2014 was -0.011 (Feb. 2014 ) + -0.063 (May. 2014 ) + -0.02 (Aug. 2014 ) + -0.027 (Nov. 2014 ) = $-0.12 Mil.
Cryo-Cell International Inc Annual Data
Cryo-Cell International Inc Quarterly Data